IP Library Patent Application 13206056
Patent Application
App. No. 13/206,056

METHODS FOR PRODUCING NONADHERENT AVIAN CELL LINES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/206,056
Abstract

The present invention relates to a method for producing avian cell lines, comprising gradual or complete withdrawal of growth factors, serum and/or feeder layer so that the established lines are adherent or nonadherent cells capable of proliferating indefinitely in a basic culture medium. The invention also relates to the cells derived from such lines which are particularly useful for the production of substances of interest.

Claims (37)

1 . An avian cell line obtained from embryonic stem cells of fertilized eggs characterized by a status of proliferation and non differentiation wherein said cell line is capable of proliferating in a basal culture medium free of exogenous growth factors and cytokines, serum, and/or feeder layer for at least 50 days and wherein said cell line has at least one of the following features:

a very visible nucleola and very small nucleoplasm,

an endogenous alkaline phosphatase activity,

an endogenous telomerase activity, and

reactivity with specific antibodies selected from the group of antibodies SSEA-1 (TEC01), SSEA-3 and EMA-1.

2 . The avian cell line according to claim 1 , wherein said embryonic stem cells originate from blastodermal disks of fertilized eggs.

3 . The avian cell line according to claim 1 , wherein said embryonic stem cells are chicken embryonic stem cells.

4 . The avian cell line according to claim 1 , wherein said cell line has been obtained by a method comprising the following steps:

a) culturing embryonic stem cells obtained from blastodermal disks of fertilized eggs in a culture medium comprising:

at least a growth factor selected from the group of SCF, IGF-1 and bFGF and at least one cytokine selected from LIF, IL-11, IL-6, IL-6R, CNTF, oncostatin and cardiotrophin;

an inactivated feeder layer of STO cells; and

fetal calf serum at a concentration of 12 to 8%,

b) after about twenty passages, modifying the culture medium:

by gradual withdrawal of said growth factors and cytokines; or

by gradual withdrawal of the feeder layer; or

by decreasing the fetal calf serum concentration to reach a low concentration of 2%, tending toward 0% (serum-free medium), and

c) establishing adherent or non-adherent cell lines capable of proliferating in a basic medium in the absence of exogenous growth factors and cytokines, serum or the inactivated feeder layer.

5 . The avian cell line according to claim 4 , wherein the cell culture medium of step a) contains at least one cytokine, bFGF, and SCF.

6 . The avian cell line according to claim 4 , wherein the cell culture medium of step a) contains at least the growth factors and cytokines consisting of SCF, IGF-1, CNTF, IL-6, soluble IL-6R, and bFGF.

7 . The avian cell line according to claim 6 , wherein that the cell culture medium of step a) further contains IL-11.

8 . The avian cell line according to claim 4 , wherein the culture medium modification of step b) comprises gradual withdrawal of said growth factors and cytokines followed by progressive deprivation of said feeder layer of STO cells and/or the decreasing of the concentration of fetal calf serum to reach a low concentration of 2%, tending toward 0% (serum-free medium).

9 . The avian cell line according to claim 1 , wherein said cell line is an adherent cell line.

10 . The avian cell line according to claim 1 , wherein said cell line is a non-adherent cell line.

11 . The avian cell line according to claim 10 , wherein said non-adherent cell line has been obtained by inoculating the cells obtained in step c) at high-density into a bacteriological dish followed by several passages in mere dilution.

12 . The avian cell line according to claim 11 , wherein the initial inoculation density is of at least 1×10 6 cells/mL.

13 . The avian cell line according to claim 1 , characterized by a status of proliferation and non differentiation and wherein said cell line has the following features:

a very visible nucleola and very small nucleoplasm,

an endogenous alkaline phosphatase activity,

an endogenous telomerase activity, and

reactivity with specific antibodies selected from the group of antibodies SSEA-1 (TEC01), SSEA-3 and EMA-1.

14 . The avian cell line according to claim 13 , wherein said cell line presents reactivity with an antibody selected from the group consisting of antibodies SSEA-1 (TEC01) and EMA-1.

15 . The avian cell line according to claim 1 , wherein said cell line is capable of proliferating for at least 100 days.

16 . The avian cell line according to claim 1 , wherein said cell line is capable of proliferating for at least 150 days.

17 . The avian cell line according to claim 1 , wherein said cell line is capable of proliferating for at least 300 days.

18 . The avian cell line according to claim 1 , wherein said cell line is capable of proliferating for at least 600 days.

19 . The avian cell line according to claim 1 , wherein said basal culture medium is selected from the group of medium consisting of DMEM, GMEM, HamF12, and McCoy's 5A supplemented with additives.

20 . The avian cell line according to claim 19 , wherein said additives are chosen from non-essential amino acids, vitamins, and sodium pyruvate.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Nov 10, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
To: VALNEVA AUSTRIA GMBH; VALNEVA SE; VALNEVA USA, INC.
Reel/Frame 073516/0522 →
SECURITY INTEREST Recorded Mar 4, 2020
From: VALNEVA SE; VALNEVA USA, INC.; VALNEVA AUSTRIA GMBH
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 052016/0745 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CHANGE OF NAME RECORDATION PREVIOUSLY RECORDED ON REEL 031607 FRAME 0481. ASSIGNOR(S) HEREBY CONFIRMS THE CONVEYING PARTY: VIVALIS RECEIVING PARTY: VALNEVA. Recorded Dec 12, 2013
From: VIVALIS
To: VALNEVA
Reel/Frame 031804/0451 →
CHANGE OF NAME Recorded Nov 15, 2013
From: VIVALIS SA
To: VALNEVA SE
Reel/Frame 031607/0481 →